News

Biogen Pharmachem Industries Limited informed the BSE that the trading window for dealing in the company`s securities will be closed from October 1, 2026, until 48 hours after the announcement of the unaudited financial results for the second quarter ended September 30, 2026, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Biogen Pharmachem Industries Limited informed the BSE that the register of members and share transfer books will remain closed from September 22, 2026, to September 29, 2026, for the Annual General Meeting, with electronic voting commencing on September 26, 2026, at 09:00 A.M. and concluding on September 28, 2026, at 05:00 P.M., with a cut-off date of September 22, 2026, to determine voting eligibility.

Net profit of Biogen Pharmachem Industries declined 83.58% to Rs 0.22 crore in the quarter ended June 2026 as against Rs 1.34 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 and during the previous quarter ended June 2025.Powered by Capital Market - Live News

Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 5 August 2026.

Net loss of Biogen Pharmachem Industries reported to Rs 0.36 crore in the quarter ended March 2026 as against net profit of Rs 1.18 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.For the full year,net profit reported to Rs 0.86 crore in the year ended March 2026 as against net loss of Rs 0.29 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.Powered by Capital Market - Live News